Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01887886
Brief Title: A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

First Submitted : June 25, 2013
First Submitted that Met QC Criteria : June 25, 2013
First Posted : June 27, 2013 (Estimate)

Certification/Extension First Submitted : July 20, 2016
Certification/Extension First Submitted that Met QC Criteria : July 20, 2016
Certification/Extension First Posted : July 22, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 1, 2016
Last Update Posted : November 2, 2016 (Estimate)